MERISTEM THERAPEUTICS Trademark

[ Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies ]

[ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and celluloses, all obtained from plants ]

[ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic regents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ]

Scientific and industrial research, namely, biotechnology research on chemical products intended for industry, science, photography, agriculture, horticulture, forestry, on pharmaceutical or cosmetic proteins obtained from plants, on pharmaceutical products, veterinary products, hygiene products within the pharmaceutical field, on dietary products for children, on biotechnology products obtained from plants; biological and biotechnological services, namely, genetic modification of plants and plant cells, embryos, cals, seeds, pollen leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, and field trials of genetically modified plants; expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biotechnology laboratories; engineering work and research and development in plant biotechnology